AVIDITY PARTNERS MANAGEMENT LP
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | CNTX | 5.00M | $11.80M |
 | DNTH | 2.10M | $184.75M |
 | SCYX | 2.08M | $1.94M |
 | JBIO | 1.40M | $34.18M |
 | ORKA | 760K | $52.02M |
 | IMUX | 670K | $6.44M |
 | VIR | 619K | $6.33M |
 | AKTS | 469K | $8.79M |
 | KPTI | 464K | $3.85M |
 | ELVN | 400K | $16.49M |
 | TENX | 266K | $3.49M |
 | PHAT | 249K | $2.79M |
 | PTON | 200K | $1.09M |
 | TEVA | 200K | $7.01M |
 | AVR | 150K | $922.50K |
 | ABUS | 125K | $525.00K |
 | CRVS | 115K | $1.75M |
 | MDT | 100K | $8.10M |
 | DXCM | 100K | $5.96M |
 | RGEN | 78K | $9.20M |
Context Therapeutics Inc.
CNTX
Shares Held
5.00M
Value
$11.80M
Dianthus Therapeutics, Inc.
DNTH
Shares Held
2.10M
Value
$184.75M
SCYNEXIS, Inc.
SCYX
Shares Held
2.08M
Value
$1.94M
Jade Biosciences, Inc.
JBIO
Shares Held
1.40M
Value
$34.18M
Oruka Therapeutics, Inc.
ORKA
Shares Held
760K
Value
$52.02M
Immunic, Inc.
IMUX
Shares Held
670K
Value
$6.44M
Vir Biotechnology, Inc.
VIR
Shares Held
619K
Value
$6.33M
Aktis Oncology, Inc.
AKTS
Shares Held
469K
Value
$8.79M
Karyopharm Therapeutics Inc.
KPTI
Shares Held
464K
Value
$3.85M
Enliven Therapeutics, Inc.
ELVN
Shares Held
400K
Value
$16.49M
Tenax Therapeutics, Inc.
TENX
Shares Held
266K
Value
$3.49M
Phathom Pharmaceuticals, Inc.
PHAT
Shares Held
249K
Value
$2.79M
Peloton Interactive, Inc.
PTON
Shares Held
200K
Value
$1.09M
Teva Pharmaceutical Industries Limited
TEVA
Shares Held
200K
Value
$7.01M
Anteris Technologies Global Corp.
AVR
Shares Held
150K
Value
$922.50K
Arbutus Biopharma Corporation
ABUS
Shares Held
125K
Value
$525.00K
Corvus Pharmaceuticals, Inc.
CRVS
Shares Held
115K
Value
$1.75M
Medtronic plc
MDT
Shares Held
100K
Value
$8.10M
DexCom, Inc.
DXCM
Shares Held
100K
Value
$5.96M
Repligen Corporation
RGEN
Shares Held
78K
Value
$9.20M